Anthracycline-Functionalized Dextran as a New Signal Multiplication Tagging Approach for Immunoassay
Biosensors · 2023
DOI: 10.3390/bios13030340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, 2023. Verfasst von Fatema Kaladari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8521, Japan. Hauptthemen laut MEDLINE: Biotin, Dextrans. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Scientific Research and Technology, Ministry of Education, Culture, Sports, Science and Technology.
Abstract (Originalsprache)
The most used kind of immunoassay is enzyme-linked immunosorbent assay (ELISA); however, enzymes suffer from steric effects, low stability, and high cost. Our research group has been developing quinone-linked immunosorbent assay (QuLISA) as a new promising approach for stable and cost-efficient immunoassay. However, the developed QuLISA suffered from low water-solubility of synthesized quinone labels and their moderate sensitivity. Herein, we developed a new approach for signal multiplication of QuLISA utilizing the water-soluble quinone anthracycline, doxorubicin, coupled with dextran for signal multiplication. A new compound, Biotin-DexDox, was prepared in which doxorubicin was assembled on oxidized dextran 40, and then it was biotinylated. The redox-cycle-based chemiluminescence and the colorimetric reaction of Biotin-DexDox were optimized and evaluated, and they showed very good sensitivity down to 0.25 and 0.23 nM, respectively. Then, Biotin-DexDox was employed for the detection of biotinylated antibodies utilizing avidin as a binder and a colorimetric assay of the formed complex through its contained doxorubicin redox reaction with NaBH4 and imidazolium salt yielding strong absorbance at 510 nm. The method could detect the plate-fixed antibody down to 0.55 nM. Hence, the application of Biotin-DexDox in QuLISA was successfully demonstrated and showed a significant improvement in its sensitivity and applicability to aqueous assays.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8521, Japan.
- School of Pharmaceutical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8521, Japan.
- Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
ORCID-Profile: Naoya Kishikawa, Mahmoud El-Maghrabey
Förderung
- Academy of Scientific Research and Technology
- Ministry of Education, Culture, Sports, Science and Technology
Zitieren
APA
Kaladari, F., Kishikawa, N., Shimada, A., El-Maghrabey, M., & Kuroda, N. (2023). Anthracycline-Functionalized Dextran as a New Signal Multiplication Tagging Approach for Immunoassay. Biosensors. https://doi.org/10.3390/bios13030340
Vancouver
Kaladari F, Kishikawa N, Shimada A, El-Maghrabey M, Kuroda N. Anthracycline-Functionalized Dextran as a New Signal Multiplication Tagging Approach for Immunoassay. Biosensors. 2023. doi:10.3390/bios13030340
BibTeX
@article{Kaladari2023,
author = {Kaladari, Fatema and Kishikawa, Naoya and Shimada, Ai and El-Maghrabey, Mahmoud and Kuroda, Naotaka},
title = {Anthracycline-Functionalized Dextran as a New Signal Multiplication Tagging Approach for Immunoassay},
journal = {Biosensors},
year = {2023},
doi = {10.3390/bios13030340}
}
EUVIMED